Real-World Evidence Solutions Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

1
Global Real-World Evidence Solutions Market
Research and Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Real-World Evidence Solutions Market
  Global Industry Trends, Share, Size, Growth,
  Opportunity and Forecast 2024-2032," the global
  real-world evidence solutions market size reached
  US 1.8 Billion in 2023.
• Factors Affecting the Growth of the Real-World
  Evidence Solutions Industry
• Growing Data Sources and Integration Techniques
• With the increasing digitization of healthcare
  records and the proliferation of wearable
  technology, vast amounts of health-related data
  are being generated. This expansion allows for a
  more comprehensive understanding of patient
  outcomes in real-world settings. Moreover,
  advancements in data integration technologies
  facilitate the merging of diverse data types,
  including electronic health records (EHRs),
  insurance claims, and patient-reported outcomes.
• This integration enhances the quality and
  granularity of real-world evidence (RWE), making
  it more valuable for healthcare decision-making.
  This evolution is pivotal for pharmaceutical
  companies, regulatory agencies, and healthcare
  providers, as it enables more informed decisions
  regarding drug development, market access
  strategies, and treatment approaches.

4
Report Highlight and Description

• Regulatory Environment and Policy Support
• Regulatory agencies are recognizing the
  importance of RWE in supplementing randomized
  controlled trial (RCT) data. This recognition is
  translating into guidelines and frameworks that
  encourage the use of RWE in the approval of new
  drugs and the expansion of existing drug
  indications.
• Additionally, policies advocating for the
  adoption of EHRs and the interoperability of
  health data systems are encouraging the use of
  RWE by improving the accessibility and quality of
  real-world data. This regulatory support ensures
  that RWE continues to play a crucial role in the
  evidence hierarchy, influencing drug development,
  market access, and post-market surveillance
  strategies.
• Technological Advancements in Data Analytics
• The development and application of sophisticated
  analytical tools and algorithms, including
  artificial intelligence (AI) and machine learning
  (ML), are enhancing the ability to process and
  analyze large datasets. These technologies
  facilitate the extraction of meaningful insights
  from complex and unstructured real-world data,
  enabling more accurate and efficient analyses
  than previously possible.

5
Report Highlight and Description

• The ability to quickly derive actionable insights
  from vast amounts of data is invaluable for
  pharmaceutical companies, healthcare providers,
  and policymakers. This capability supports a wide
  array of applications, ranging from drug
  development and patient monitoring to health
  economics and outcomes research.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/real-world-evidence-sol
  utions-market/requestsample

6
Report Description

• Global Real-World Evidence Solutions Market
  Trends
• The growing integration of RWE with digital
  health technologies, such as telehealth services,
  mobile health (mHealth) apps, and wearable
  devices, for collecting and analyzing health data
  in real time is offering a more dynamic and
  continuous insight into patient health and
  behavior outside of traditional healthcare
  settings. Digital health technologies enable the
  capture of a vast array of data points, ranging
  from physiological metrics to patient-reported
  outcomes, which can be analyzed using RWE
  methodologies to generate more personalized and
  timely insights into treatment effectiveness and
  patient adherence.
• This convergence of digital health and RWE opens
  novel avenues for healthcare innovation, allowing
  for the development of more holistic and
  patient-centered care models that can adapt to
  the changing needs and conditions of patients in
  real-time.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/real-world-evidence-sol
  utions-market

7
Report Segmentation

• Breakup by Component
• Clinical Settings Data
• Claims Data
• Patient-Powered Data
• Pharmacy Data
• Others
• Breakup by Therapeutic Area
• Oncology
• Immunology
• Neurology
• Cardiovascular Disease
• Others

8
Report Segmentation

• Breakup by End User
• Pharmaceutical and Medical Device Companies
• Healthcare Payers
• Healthcare Providers
• Others
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

9
Competitive Landscape with Key Players

• Aetion Inc.
• Clinigen Limited
• Flatiron Health Inc. (Roche Holding AG)
• ICON plc
• International Business Machines Corporation
• IQVIA
• Optum Inc. (UnitedHealth Group Incorporated)
• Oracle Corporation
• Parexel International Corporation
• PPD Inc. (Thermo Fisher Scientific Inc.)
• Sas Institute Inc.
• Syneos Health

10
Key Questions Answered in the Report
11
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Real-World Evidence
  Solutions Market    5.1    Market Overview   
  5.2    Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Component
• 6.1 Clinical Settings Data
• 6.1.1 Market Trends
• 6.1.2 Market Forecast
• 6.2 Claims Data
• 6.2.1 Market Trends
• 6.2.2 Market Forecast
• 6.3 Patient-Powered Data
• 6.3.1 Market Trends
• 6.3.2 Market Forecast       

12
Table of Contents

• 6.4 Pharmacy Data
• 6.4.1 Market Trends
• 6.4.2 Market Forecast
• 6.5 Others
• 6.5.1 Market Trends
• 6.5.2 Market Forecast
• 7 Market Breakup by Therapeutic Area
• 7.1 Oncology
• 7.1.1 Market Trends
• 7.1.2 Market Forecast
• 7.2 Immunology
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 7.3 Neurology
• 7.3.1 Market Trends
• 7.3.2 Market Forecast
• 7.4 Cardiovascular Disease
• 7.4.1 Market Trends
• 7.4.2 Market Forecast

13
Partial List of Clients
14
Partial List of Clients
15
Disclaimer

• 2024 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

16
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us